Dr. Rao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7130 N Millbrook Ave
Fresno, CA 93720Phone+1 559-326-1222Fax+1 559-326-1225
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2000 - 2004
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1997 - 2000
All India Institute of Medical SciencesClass of 1997
Certifications & Licensure
CA State Medical License 2008 - 2025
MN State Medical License 2000 - 2008
WI State Medical License 1998 - 2001- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Start of enrollment: 2004 Feb 01
- Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System Start of enrollment: 2004 Jan 01
- Everolimus in Treating Patients With Stage IV Melanoma Start of enrollment: 2005 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 60 citationsMammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer AgentsRavi D. Rao, Jan C. Buckner, Jann N. Sarkaria
Current Cancer Drug Targets. 2004-11-30 - 79 citationsDisruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells.Ravi D. Rao, Ann C. Mladek, Jeffrey D. Lamont, Jennie M. Goble, Charles Erlichman
Neoplasia. 2005-10-01 - 262 citationsMalignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and DiagnosisSvetomir N. Markovic, Lori A. Erickson, Ravi D. Rao, Robert R. McWilliams, Lisa A. Kottschade
Mayo Clinic Proceedings. 2007-03-01
Press Mentions
Cancer Patients Are Being Denied Drugs, Even with Doctor Prescriptions and Good InsuranceAugust 2nd, 2019
How the Shortage of a $15 Cancer Drug Is Upending TreatmentJune 27th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
